The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma

被引:0
|
作者
Di He
Qin Xu
Ming Yan
Ping Zhang
Xiaojian Zhou
Zhiyuan Zhang
Wenhu Duan
Laiping Zhong
Dongxia Ye
Wantao Chen
机构
[1] Shanghai Jiao Tong University School of Medicine,Department of Oral and Maxillofacial Surgery, College of Stomatology, Ninth People's Hospital
[2] Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology,Laboratory of Oral Tumor and Oral Biology
[3] Chinese Academy of Sciences,Department of Medicinal Chemistry, Shanghai Institute of Materia Medica
[4] Zhejiang University School of Medicine,Department of Oral and Maxillofacial Surgery, Second Affiliated Hospital
来源
BMC Cancer | / 9卷
关键词
Oral Squamous Cell Carcinoma; Electrophoretic Mobility Shift Assay; Oral Squamous Cell Carcinoma; Oral Squamous Cell Carcinoma Cell; Celastrol;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma
    He, Di
    Xu, Qin
    Yan, Ming
    Zhang, Ping
    Zhou, Xiaojian
    Zhang, Zhiyuan
    Duan, Wenhu
    Zhong, Laiping
    Ye, Dongxia
    Chen, Wantao
    BMC CANCER, 2009, 9 : 343
  • [2] NF-kappa B acts as a multifunctional modulator in bone invasion by oral squamous cell carcinoma
    Jimi, Eijiro
    Kokabu, Shoichiro
    Matsubara, Takuma
    Nakatomi, Chihiro
    Matsuo, Kou
    Watanabe, Seiji
    ORAL SCIENCE INTERNATIONAL, 2016, 13 (01) : 1 - 6
  • [3] ACTIVATION OF NF-kappa B IN THE CISPLATIN-INDUCED APOPTOSIS OF ORAL SQUAMOUS CELL CARCINOMA
    Seo, Jong-Chun
    Sung, Iel-Yong
    Kim, Jong-Roul
    JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, 2006, 32 (02) : 94 - 100
  • [4] GPR108 is required for gambogic acid inhibiting NF-kappa B signaling in cancer
    Lyu, Song
    Zhang, Xue
    Tu, Zhenzhen
    Zhou, Haisheng
    Ke, Xisong
    Qu, Yi
    PHARMACOLOGICAL RESEARCH, 2022, 182
  • [5] Ubiquitin D Promotes Progression of Oral Squamous Cell Carcinoma via NF-Kappa B Signaling
    Song, An
    Wang, Yi
    Jiang, Feng
    Yan, Enshi
    Zhou, Junbo
    Ye, Jinhai
    Zhang, Hongchuang
    Ding, Xu
    Li, Gang
    Wu, Yunong
    Zheng, Yang
    Song, Xiaomeng
    MOLECULES AND CELLS, 2021, 44 (07) : 468 - 480
  • [6] Synergism between NF-kappa B inhibitor, celastrol, and XIAP inhibitor, embelin, in an acute myeloid leukemia cell line, HL-60
    Pazhang, Yaghub
    Jaliani, Hossein Zarei
    Imani, Mehdi
    Dariushnejad, Hassan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (01) : 155 - 160
  • [7] Apoptotic effect of gambogic acid in esophageal squamous cell carcinoma cells via suppression of the NF-κB pathway
    Liu, Wen-Yue
    Wu, Xu
    Liao, Cheng-Quan
    Shen, Jie
    Li, Jun
    ONCOLOGY LETTERS, 2016, 11 (06) : 3681 - 3685
  • [8] Anti-cancer effects of a selective COX-2 inhibitor celecoxib in oral squamous cell carcinoma
    Lee, E. J.
    Han, K. D.
    Myoung, H.
    Lee, J. H.
    Kim, M. J.
    ORAL ONCOLOGY, 2007, : 195 - 195
  • [9] Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion
    Myoung, H
    Hong, SP
    Yun, PY
    Lee, JH
    Kim, MJ
    CANCER SCIENCE, 2003, 94 (02) : 215 - 220
  • [10] Effect of a novel NF-kappa B inhibitor, IMD-0354, on human hematopoietic cell malignancies
    Tanaka, A
    Konno, M
    Hebishima, T
    Muto, S
    Itai, A
    Matsuda, H
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 88 - 88